The US government will pay American pharmaceutical leader Pfizer and German biotech BioNTech $1.95 billion USD to buy enough COVID-19 vaccines for approximately 50 million people. Pfizer and BioNTech will not receive payment until their vaccines are proved both safe and effective through large clinical trials. The contract sets for approximately 100 million doses of the vaccine, individually valued at $39 USD, with one treatment cycle of two-dose treatment. The government would also have the opportunity to procure an additional 500 million doses, to be negotiated separately. If the vaccine is proven to be successful, the US department of Human Services (HHS) has announced that it will be made available for Americans at no additional cost, though insurances may be charged for the treatment.
Read more here.